humanitarian Archived signal

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 20, 2026 · 09:45 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised09:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised09:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 13, Status: Authorised09:16 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 13, Status: Authorised09:16 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 6, Status: Authorised09:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 6, Status: Authorised09:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 14, Status: Authorised09:04 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 14, Status: Authorised09:04 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised06:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised06:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 29, Status: Authorised06:55 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 29, Status: Authorised06:55 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 20 · 10:13 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 20 · 10:21 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →